All In Biotech

Drug Trial Radar · NCT04293679

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Last checked: Nov 19, 2026Latest source record: Jun 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Mar 21, 2019

Primary completion

Oct 21, 2020

Study completion Oct 21, 2020

Sponsor

Lead sponsor
SirnaomicsIndustry
Sponsor type
Industry
Collaborators
Amarex Clinical Research
First posted
Mar 3, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open label, dose escalation study to evaluate the safety and efficacy of intralesional injection of STP705 in adult patients with Cutaneous Squamous Cell Carcinoma in situ (isSCC, Bowen's disease). The purpose of this trial is to evaluate the safety, tolerability and efficacy of various doses of STP705 administered as Intralesional injection in subjects with isSCC. Goals: * To determine the safe and effective recommended dose of STP705 for the treatment of isSCC. * Analysis of biomarkers common to isSCC formation pathway including TGF-β1 and COX-2.

Conditions

  • Bowen's Disease
  • Cutaneous Squamous Cell Carcinoma in Situ

Interventions

  • STP705Drug

    Investigational Product

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with histological clearance of treated isSCC lesion at the End of Treatment (EOT).Time frame: 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Center for Clinical and Cosmetic Research

    Aventura, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.